| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.30 |
| 52 Week High | CN¥25.50 |
| 52 Week Low | CN¥14.81 |
| Beta | 0.53 |
| 11 Month Change | -0.67% |
| 3 Month Change | -3.72% |
| 1 Year Change | -32.51% |
| 33 Year Change | -40.70% |
| 5 Year Change | 34.38% |
| Change since IPO | 72.03% |
Recent News & Updates
Shareholder Returns
| 002932 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 4.3% | 0.8% | 5.4% |
| 1Y | -32.5% | -20.2% | -16.2% |
Return vs Industry: 002932 underperformed the CN Medical Equipment industry which returned -20.2% over the past year.
Return vs Market: 002932 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
| 002932 volatility | |
|---|---|
| 002932 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 002932 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002932's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,547 | Chen Li Li | www.mdeasydiagnosis.com |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Fundamentals Summary
| 002932 fundamental statistics | |
|---|---|
| Market cap | CN¥3.56b |
| Earnings (TTM) | CN¥27.52m |
| Revenue (TTM) | CN¥366.25m |
132.8x
P/E Ratio10.0x
P/S RatioIs 002932 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002932 income statement (TTM) | |
|---|---|
| Revenue | CN¥366.25m |
| Cost of Revenue | CN¥97.16m |
| Gross Profit | CN¥269.09m |
| Other Expenses | CN¥241.57m |
| Earnings | CN¥27.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 73.47% |
| Net Profit Margin | 7.51% |
| Debt/Equity Ratio | 0.05% |
How did 002932 perform over the long term?
See historical performance and comparison